However, the tumor burdens were significantly higher in Shp2ΔHK mice than in Shp2ΔH mice (Figure 4B and C), suggesting that concurrent removal of Shp2 from both KCs and hepatocytes further promoted HCC progression. This evidence concerns the gene PTPN11 and hepatocellular carcinoma.